Drug intelligence / Profile preview

prothrombin complex concentrate (human) (Hebei Da'an Pharmaceutical)

Development stage
Approved
Lead developer
Hebei Da'an Pharmaceutical
Administration
Intravenous
01

Overview

Prothrombin complex concentrate (human) is a human plasma-derived biologic product containing vitamin K-dependent coagulation factors — primarily Factor II (prothrombin), Factor IX, and Factor X, and potentially Factor VII. Developed by Hebei Da'an Pharmaceutical Co., Ltd., it is used to treat hemophilia B (Factor IX deficiency) by replacing the deficient factors and restoring the coagulation cascade. The drug is a 3- or 4-factor prothrombin complex concentrate (PCC) administered by intravenous injection. It is currently being evaluated in a Phase 3, single-arm, open-label clinical trial in China (CTR20180124) to assess its efficacy and safety in treating hemophilia B using an objective performance criterion (target value method).

Other names
human prothrombin complexPCC3-factor prothrombin complex concentrate4-factor prothrombin complex concentrate
02

Targets

PROC (Protein C)F9 (Coagulation Factor IX)F2 (Thrombin)F10 (Factor Xa)F7 (Coagulation Factor VII)

Beyond the preview

Go deeper on prothrombin complex concentrate (human) (Hebei Da'an Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prothrombin complex concentrate (human) (Hebei Da'an Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call